• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
COVID-19: Pregnancy
CMECNE

ACOG COVID-19 FAQs for Obstetrical Care

image_pdfFavoriteLoadingFavorite

Learning Objectives and CME/Disclosure Information

This activity is intended for healthcare providers delivering care to women and their families.

After completing this activity, the participant should be better able to:

1. Discuss elements of obstetrical care that may be modified due to the COVID-19 pandemic
2. List the obstetrical practices and procedures where standard guidelines should be followed despite the COVID-19 pandemic

Estimated time to complete activity: 0.5 hours

Faculty:

Susan J. Gross, MD, FRCSC, FACOG, FACMG
President and CEO, The ObG Project

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty: Susan J. Gross, MD, receives consulting fees from Cradle Genomics, and has financial interest in The ObG Project, Inc.

Planners and Managers: The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

Method of Participation and Request for Credit

Fees for participating and receiving CME credit for this activity are as posted on The ObG Project website. During the period from through , participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation. Upon registering and successfully completing the post-test with a score of 100% and the activity evaluation, your certificate will be made available immediately.

For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The ObG Project. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Designated for 0.1 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

Read Disclaimer & Fine Print

NOTE: Information and guidelines may change rapidly. Check in with listed references in ‘Learn More – Primary Sources’ to best keep up to date. This entry has been updated with additional information on counseling patients working in a non-healthcare setting.

SUMMARY:

ACOG has released FAQs that address common questions faced by obstetrical care professionals. The recommendations in this document reinforce CDC guidance and clarify some issues specific to obstetrics. Below are highlighted FAQs from the document (please see ‘Learn More – Primary Sources’ below for link to complete document)


  • Pregnant Healthcare Workers
  • Pregnant Women in Non-Healthcare Settings 
  • Masks
  • NSAIDs
  • Antenatal Corticosteroids for Lung Maturity
  • Postpartum Contraception
  • Expedited Discharge Planning
  • Postpartum Visits
  • Clinical Guidelines that Remain Unchanged
  • PPH: Use of TXA and Hemabate 
  • Visitation Policies During COVID-19

Pregnant Healthcare Workers

  • A CDC study found that pregnant women with COVID-19 may be at higher risk for adverse outcomes and pregnancy is now listed in the ‘increased risk’ category
    • However, the study had significant limitations (e.g. a substantial amount of missing data) and detailed stratification by gestational or medical comorbidities is not currently available
  • ACOG recommends that for pregnant healthcare personnel
    • “Health care facilities may consider limiting exposure of pregnant health care personnel to patients with confirmed or suspected COVID-19 infection, especially during higher risks procedures (CDC)”
    • Women can continue to work up until delivery if they so choose and appropriate, recommended PPE is available
    • Any recommendations related to comorbidities for nonpregnant individuals should be applied to pregnant individuals as well
  • If recommended PPE is not available
    • Avoid exposure to high-risk procedures
    • Healthcare personnel are not “ethically obligated” to engage in high-risk procedures in the absence of recommended PPE

Pregnant Women in Non-Healthcare Settings

  • With the addition of pregnancy to the CDC ‘increased risk’ category, pregnant women
    • Should “be provided the ability to occupy roles” with less risk of exposure
    • Can opt to work until delivery
  • Employers should
    • Follow current CDC guidance
    • Assess potential hazards and ensure workers “use controls to prevent exposure (Department of Labor)”
  • In the event that a pregnant woman requests a letter to support a COVID-19 specific work accommodation, aside from advocating for infection protection, ACOG states that

…maternal health care professionals can respond to the request in the context of the risk to the pregnant individual considering the particular patient’s circumstances

Masks

For Pregnant Women

  • Should be worn in setting of COVID-19 symptoms or confirmed COVID-19 when in public or around others
  •  For other individuals, especially those in areas of significant community-based spread, cloth face coverings are recommended in public settings where other social distancing measures are difficult to maintain (eg, grocery stores and pharmacies | CDC specifies cloth vs surgical masks or respirators as these PPE items, currently in short supply, should be reserved for healthcare personnel

Obstetrical Healthcare Workers

  • ACOG
    • Healthcare providers should use PPE, including respirators or face masks, goggles, gowns and gloves | N95 respirators should be used for aerosol-generating procedures
    • ACOG states that “COVID-19 infection is highly contagious, and this must be taken into consideration when planning intrapartum care”
    • In addition to wearing appropriate PPE, respirators (e.g., N95 masks) should be worn by “All medical staff caring for potential or confirmed COVID-19 patients” when available
    • In the setting of limited infection protections “physicians are not ethically obligated to provide care to high-risk patients without protections in place”
  • PPE: ACOG reviews CDC guidance
    • Respirators (e.g., N95 respirators) should be used when caring for patients with confirmed or suspected COVID-19
    • Aerosol-generating procedures should be prioritized during shortages
    • ACOG restates the CDC opinion that second stage is not considered an aerosol-generating procedure and adds the following

ACOG continues to review questions and data regarding the potential for aerosolization in the context of forceful exhalation during the second stage of labor 

  • ‘Expert Review’ (Berghella. AJOG MFM, 2020)
    • Healthcare workers including ObGyns and other obstetric care professionals “are one of the populations at highest risk of contracting the disease and dying from it”
    • All obstetrical healthcare workers coming into contact with patients – both inpatient (L&D) and outpatient setting – should wear PPE
    • COVID-19 testing: All patients should be tested for COVID-19 on admission to hospital at least once and more often if symptomatic or there is concern over exposure
      • If patient positive for COVID-19: Obstetrical healthcare workers should wear N-95 mask or equivalent
  • ‘Expert Review’ (Boelig et al. AJOG MFM, 2020)
    • The authors acknowledge that there may be logistical issues but state the goal should be that

N95 mask should be worn in addition to droplet precaution PPE for any patients with suspected or confirmed COVID, and for any patient, regardless of respiratory symptoms, during indispensable aerosolizing procedures, including second stage of labor

NSAIDs

  • No evidence of association between NSAIDs, such as ibuprofen, and COVID-19 exacerbation
  • Preeclampsia prophylaxis

…low-dose aspirin should continue to be offered to pregnant and postpartum women as medically indicated

For patients with suspected or confirmed COVID-19 for whom low-dose aspirin would be indicated, modifications to care may be individualized

Antenatal Corticosteroids for Lung Maturity

  • Data indicates that corticosteroids may play a beneficial role in the treatment of severely ill patients with COVID-19 (see ‘NIH COVID-19 Treatment Guidelines’ in ‘Related ObG Topics’ below)
  • Based on the above

ACOG now recommends offering antenatal corticosteroids, as indicated, for fetal benefit

Postpartum Contraception

  • Discuss benefits of immediate postpartum LARC
  • Tubal sterilization
    • Unless the patient is at high risk, “it may be appropriate to temporarily consider tubal sterilization only when performing cesarean birth”

Expedited Discharge Planning

  • “May be considered”
    • Uncomplicated vaginal delivery: Day 1
    • Cesarean delivery: Day 2
  • Dependent on mother and infant health
  • Follow-up planning
    • Coordinate with pediatric team
    • Telehealth for outpatient visits

Postpartum Visits

  • Frequency and timing may be modified to prevent exposures
    • Should be determined at local level
  • Modification examples include
    • Telehealth for the following
      • Initial 3 week assessment (or sooner) | Wound checks | Blood Pressure checks
    • In-person visit for comprehensive postpartum visit | Delay to 12 weeks | Consider earlier visit if the patient may lose insurance prior to 12 weeks

KEY POINTS:

Clinical Guidelines that Remain Unchanged

Continue to Manage According to Current Clinical Guidance

  • GBS screening between 36w0d to 37w6d
    • Option: Patient may self-collect specimen if infrastructure available
  • Timing of delivery
    • COVID-19 should generally not impact timing of delivery
    • Exception: If a woman is infected in the third trimester and there are no medical indications to the contrary, “it is reasonable” to try and postpone delivery until there is a negative test result or quarantine lifted
  • Induction of labor
  • Operative delivery
  • Mode of delivery
  • Delayed cord clamping
  • Cord blood banking management
  • Home birth counseling
  • Antenatal and fetal surveillance
    • Try to limit to situations where testing will provide “an expected answer to a relevant clinical question or otherwise provide medical benefit to the patient”
    • There may be circumstances where delaying or cancelling tests or encounters may be warranted if harm is greater than benefit
    • Decisions to delay or alter scheduling should be made at the local level

PPH: Use of TXA and Hemabate

TXA

  • COVID-19 appears to be a hypercoagulable state
  • TXA can be considered for the treatment of PPH in keeping with guidance for non-COVID-19 patients
  • However, the document states

Because of the possible additive effect of the increased risk of thrombosis from COVID-19 infection and the hypercoagulative state of pregnancy, it may be prudent to consider this increased likelihood of clotting before adminisitering TXA for postpartum hemorrhage

Hemabate

  • While Hemabate is not used in asthma due to risk for bronchospasm, patients with COVID-19 have respiratory symptoms consistent with viral pneumonia
  • While there is no data specific to COVID-19 and this medication, “Hemabate is not generally withheld” in patients with viral pneumonia

Visitation Policies During COVID-19

  • Visitation policy decisions are ultimately guided by
    • Local facilities and capabilities (e.g., physical space, equipment)
    • Community spread and prevalence
    • Governmental regulations and recommendations at multiple levels
  • ACOG recommends that for both inpatient and outpatient
    • Reduce number of visitors to minimum necessary
    • Limit to those individuals “essential for the pregnant individual’s well-being (emotional support persons)”
    • Screen all visitors for symptoms of respiratory illness
      • Patient should be attended to by an asymptomatic visitor
      • A visitor with fever or respiratory symptoms should not accompany the patient
  • Additional support persons
    • Encourage the use of alternative forms of interaction (e.g., video-call apps)
  • Counseling patients and families regarding restrictive visitation policies
    • Acknowledge value of support persons
    • Explain the temporary nature of the policies and that they are in place to protect everyone’s safety, including the patient, baby and community at large
  • Special considerations for underserved communities
    • Support systems including support persons are especially important throughout the delivery journey, including postpartum care
    • ACOG states that

…institutions should be mindful of how restrictions might differentially and negatively affect these communities, which in many areas are also disproportionately affected by COVID-19

Learn More – Primary Sources:

COVID-19 FAQs for Obstetrician-Gynecologists, Obstetrics

NOW!: Protection for Obstetrical providers and Patients (Berghella. AJOG MFM, 2020)

Labor and Delivery Guidance for COVID-19 (Boelig et al. AJOG MFM, 2020)

ACOG & SMFM: Joint Statement: Recent Developments Regarding COVID-19 and Pregnant Women

Take a post-test and get CME credits

TAKE THE POST TEST

Get COVID-19 Guideline Notifications direct to your phone with ObGFirst

Try it Free »

image_pdfFavoriteLoadingFavorite
< Previous
All COVID-19: Pregnancy Posts
Next >

Related ObG Topics:

COVID-19: The SMFM/SOAP Guidelines for Labor and Delivery
NIH COVID-19 Treatment Guidelines
Managing an Obstetric Office Practice During COVID-19
COVID-19 Guidance: Key Highlights for Healthcare Professionals
Coronavirus and Pregnancy: CDC Guidance and Professional Recommendations

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site